Skye Bioscience
SKYE
66 hedge funds and large institutions have $101M invested in Skye Bioscience in 2024 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 7 closing their positions.
171% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 7
110% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 10
47% more call options, than puts
Call options by funds: $87K | Put options by funds: $59K
18% more funds holding
Funds holding: 56 → 66 (+10)
2.46% less ownership
Funds ownership: 87.27% → 84.81% (-2.5%)
49% less capital invested
Capital invested by funds: $196M → $101M (-$95.7M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$5.24M |
| 2 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$5.05M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$2.96M |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$2.72M |
| 5 |
AIC
AWM Investment Company
New York
|
+$2.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$7.29M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
-$6.74M |
| 3 |
PA
Perceptive Advisors
New York
|
-$4M |
| 4 |
5VM
5AM Venture Management
San Francisco,
California
|
-$1.49M |
| 5 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$1.18M |
SKYE Hedge Fund Activity: Q3 2024 in Review
66 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Skye Bioscience (SKYE) for Q3 2024, worth a combined $101M — down 49% from $196M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new SKYE positions and 7 closed out — a net gain of 12 holders — while 21 added to existing stakes and 10 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $5.24M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $7.29M sold.
- 66 institutional investors held Skye Bioscience (SKYE) as of Q3 2024, up from 56 in Q2 2024.
- Funds reported $101M of Skye Bioscience stock for Q3 2024, down 49% quarter-over-quarter.
- 19 funds opened new Skye Bioscience positions in Q3 2024 and 7 closed out, a net change of +12 holders.
- The largest Skye Bioscience buyer in Q3 2024 was Baker Bros. Advisors, an estimated $5.24M added.
- The largest Skye Bioscience seller in Q3 2024 was Janus Henderson Group, an estimated $7.29M sold.
Based on aggregated 13F filings for Q3 2024.